ADENTRA (ADEN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
27 Apr, 2026Executive summary
Q1 2025 sales rose 1.4% year-over-year to $542.5 million, driven by the Wolf/Woolf Distributing acquisition, despite lower organic volumes due to winter weather, affordability pressures, and softness in residential construction.
Gross margin held steady at 21.6%, reflecting stable pricing and effective procurement strategies.
Adjusted EBITDA was $40 million (7.4% margin), down from $45.6 million last year; adjusted EPS fell to $0.42 from $0.76.
Net income dropped to $4.1 million from $10.7 million, with basic EPS at $0.16 versus $0.48 in Q1 2024.
Maintained disciplined cost management, with operating expense increases mainly from the Wolf/Woolf acquisition and higher warehouse costs.
Financial highlights
Total sales grew 1.4% year-over-year to $542.5 million, driven by Wolf/Woolf Distributing; U.S. organic sales declined 4.7%, while Canada grew 3%.
Gross margin was 21.6% in Q1, consistent with prior year.
Adjusted EBITDA was $40 million (7.4% margin), down from $45.6 million last year.
Adjusted EPS was $0.42, down from $0.76 a year ago.
Operating expenses rose 6.5% to $99.9 million, largely due to the Wolf/Woolf acquisition and higher warehouse costs.
Outlook and guidance
Maintains a conservative near-term outlook due to macro headwinds: high U.S. mortgage rates, tight housing supply, trade tensions, and inflation risk.
Transitioning from fixed 2028/5-year targets to a full-cycle performance framework, focusing on average outcomes across economic cycles.
Long-term framework targets: low to mid-single-digit organic growth, $50M–$150M annual M&A, gross margin above 20%, adjusted EBITDA margin 8%–10%, and ROIC of 10%–12%.
Long-term fundamentals seen as strong, supported by housing undersupply and favorable demographics.
Latest events from ADENTRA
- Margin and EPS growth, M&A, and digital initiatives drive stable outlook and long-term growth.ADEN
Q2 202427 Apr 2026 - Sales up 1.8% to $568.8M, net income up 28.7%, gross margin 21.3%, and dividend increased.ADEN
Q3 202427 Apr 2026 - Q4 sales and margins improved, net income rose, and M&A expanded reach despite headwinds.ADEN
Q4 202427 Apr 2026 - Q3 sales rose 4.1% to $592.1M, with margin gains and strong cash flow despite market headwinds.ADEN
Q3 202527 Apr 2026 - Sustained growth, strategic acquisitions, and operational excellence drive long-term value creation.ADEN
Investor presentation16 Mar 2026 - Strong growth, disciplined M&A, and operational excellence drive double-digit returns.ADEN
Investor presentation16 Mar 2026 - 2025 sales and net income grew, with robust cash flow, higher margins, and increased dividends.ADEN
Q4 202512 Mar 2026 - Q2 sales up 8.7% to $597.1M, with margin growth and strong cash flow despite trade risks.ADEN
Q2 202523 Nov 2025 - Sustained growth, strong M&A, and operational excellence drive double-digit shareholder returns.ADEN
Investor Presentation7 Aug 2025